Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial (Q29614756)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial (English)

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22735384

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

multicenter clinical trial

6 February 2020

main subject

phase III clinical trial

0 references

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Piotr Rutkowski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Vanna Chiarion Sileni

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

8

Christian U Blank

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1

Axel Hauschild

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Lev V Demidov

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Thomas Jouary

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Ralf Gutzmer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Michael Millward

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Wilson H Miller

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Eckhart Kaempgen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Salvador Martín-Algarra

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Boguslawa Karaszewska

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Cornelia Mauch

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Anne-Marie Martin

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Suzanne Swann

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Patricia Haney

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Beloo Mirakhur

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Mary E Guckert

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Vicki Goodman

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Paul B Chapman

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22735384

6 February 2020

language of work or name

1 reference

30 April 2017

publication date

25 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22735384

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

380

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22735384

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

358-365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

9839

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22735384

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960868-X

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960868-X

7 January 2021

Distinct sets of genetic alterations in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960868-X

7 January 2021

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960868-X

7 January 2021

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960868-X

7 January 2021

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960868-X

7 January 2021

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960868-X

7 January 2021

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960868-X

7 January 2021

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960868-X

7 January 2021

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960868-X

7 January 2021

10.1016/S0140-6736(12)60868-X

Identifiers

DOI

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22735384

30 April 2017

Consolidated OpenCitations Corpus – April 2017

549079

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22735384%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

549079

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22735384

3 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

549079